Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons.

Genetic studies in non-human primates serve as a potential strategy for identifying genomic intervals where polymorphisms impact upon human disease-related phenotypes. It remains unclear, however, whether independently arising polymorphisms in orthologous regions of non-human primates leads to similar variation in a quantitative trait found in both species. To explore this paradigm, we studied a baboon apolipoprotein gene cluster (APOA1/C3/A4/A5) for which the human gene orthologs have well-established roles in influencing plasma HDL-cholesterol and triglyceride concentrations. Our extensive polymorphism analysis of this 68 kb gene cluster in 96 pedigreed baboons identified several haplotype blocks each with limited diversity, consistent with haplotype findings in humans. To determine whether baboons, like humans, also have particular haplotypes associated with lipid phenotypes, we genotyped 634 well-characterized baboons using 16 haplotype tagging SNPs. Genetic analysis of single SNPs, as well as haplotypes, revealed an association of APOA5 and APOC3 variants with HDL-cholesterol and triglyceride concentrations, respectively. Thus, independent variation in orthologous genomic intervals does associate with similar quantitative lipid traits in both species, supporting the possibility of uncovering human quantitative trait loci genes in a highly controlled non-human primate model.

[1]  R. Cantor,et al.  The apoAI-CIII-AIV gene cluster. , 2001, Atherosclerosis.

[2]  S. Gabriel,et al.  Quality and completeness of SNP databases , 2003, Nature Genetics.

[3]  J. VandeBerg,et al.  A novel system for storage of sera frozen in small aliquots. , 1986, Journal of biochemical and biophysical methods.

[4]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[5]  A. Tall,et al.  ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. , 1997, Journal of lipid research.

[6]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[7]  Shotai Kobayashi,et al.  The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. , 2002, Atherosclerosis.

[8]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[9]  Bennett Dyke,et al.  Genetic determination of HDL variation and response to diet in baboons. , 2002, Atherosclerosis.

[10]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[11]  Daniel J Schaid,et al.  Caution on pedigree haplotype inference with software that assumes linkage equilibrium. , 2002, American journal of human genetics.

[12]  L. Atwood,et al.  Two major loci control variation in beta-lipoprotein cholesterol and response to dietary fat and cholesterol in baboons. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Ribalta,et al.  Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. , 2002, Clinical chemistry.

[14]  Deborah A. Nickerson,et al.  Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans , 2003, Nature Genetics.

[15]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[16]  D. Nickerson,et al.  Variation is the spice of life , 2001, Nature Genetics.

[17]  X. Adiconis,et al.  The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.M300251-JLR200 , 2003, Journal of Lipid Research.

[18]  P. Green,et al.  Consed: a graphical tool for sequence finishing. , 1998, Genome research.

[19]  D. Evans,et al.  The single nucleotide polymorphism −1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia , 2003, Journal of Molecular Medicine.

[20]  Jonathan C. Cohen,et al.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. , 2002, Human molecular genetics.

[21]  W. Shelledy,et al.  Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. , 1997, Journal of lipid research.

[22]  R. Fuerst,et al.  Haplotyping and estimation of haplotype frequencies for closely linked biallelic multilocus genetic phenotypes including nuclear family information , 2001, Human mutation.

[23]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[24]  Kun Zhang,et al.  HaploBlockFinder: Haplotype Block Analyses , 2003, Bioinform..

[25]  I. Talianidis,et al.  Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene. , 1995, Biochemistry.

[26]  M. Rieder,et al.  Sequence variation in the human angiotensin converting enzyme , 1999, Nature Genetics.

[27]  G A Churchill,et al.  Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. , 2001, Genomics.

[28]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[29]  M. Noble,et al.  Sodium-lithium countertransport activity is linked to chromosome 5 in baboons. , 2001, Hypertension.

[30]  S. Taş.  Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. , 1989, Clinical chemistry.

[31]  J. Rogers,et al.  Baboons as an animal model for genetic studies of common human disease. , 1997, American journal of human genetics.

[32]  Hao Li,et al.  Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. , 1994, The Journal of biological chemistry.

[33]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[34]  D. Nickerson,et al.  Sequence variation in the human T‐cell receptor loci , 2002, Immunological reviews.

[35]  D. Nickerson,et al.  PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.

[36]  S. Tomura,et al.  Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren , 2002, Human Genetics.

[37]  J. Rogers,et al.  A genetic linkage map of the baboon (Papio hamadryas) genome based on human microsatellite polymorphisms. , 2000, Genomics.

[38]  Medha Kulkarni,et al.  Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. , 2003, Journal of lipid research.

[39]  J. Sasaki,et al.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population , 1995, Human Genetics.

[40]  Laura A Cox,et al.  Localization of genes that control LDL size fractions in baboons. , 2003, Atherosclerosis.

[41]  D. Kardassis,et al.  Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. , 1999, Biochemistry.

[42]  E. Boerwinkle,et al.  DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.

[43]  M. Olivier,et al.  Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. , 2004, Genomics.

[44]  J. Breslow,et al.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  I. Talianidis,et al.  Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. , 1994, Nucleic acids research.

[46]  Ron Korstanje,et al.  From QTL to gene: the harvest begins , 2002, Nature Genetics.

[47]  D. Kardassis,et al.  Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[48]  E. Boerwinkle,et al.  Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[49]  G. Abecasis,et al.  Using haplotype blocks to map human complex trait loci. , 2003, Trends in genetics : TIG.

[50]  M. Olivier,et al.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. , 2002, Human molecular genetics.